Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cd Markers Polymorphisms As Prognostic Biomarkers in Hematological Malignancies Publisher



Shahrabi S1 ; Ghanavat M2 ; Behzad MM3, 4 ; Purrahman D4 ; Saki N4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biochemistry and Hematology, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran
  2. 2. Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Blood Transfusion Research Center, High Institute for Research and Education in Transfusion, Hamadan, Iran
  4. 4. Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Source: Oncology Reviews Published:2020


Abstract

The clusters of differentiation (CD) are surface molecules used for immunophenotyping of cells. The expression of CD markers is widely used to classify hematological malignancies, including leukemia and lymphoma. Single nucleotide polymorphisms (SNPs) are crucial genetic changes that can be associated with abnormal expression and function of CD markers. In this paper, we assess the prognostic effect of CD markers' SNPs in hematological malignancies. Materials and methods and relevant literature was identified by a PubMed search (2001-2019) of English language papers using the following terms: 'polymorphism', 'CD marker', 'leukemia', 'lymphoma', 'prognosis', 'CD marker', and 'polymorphism'. Many studies have demonstrated the effects of CD markers' polymorphisms on risk of hematological malignancies. Also, SNPs of CD markers can be related with clinicopathological features, invasiveness, and response to therapy of these disorders. Considering the importance of SNPs in the expressions of CD markers, these genetic changes could be used as potential prognostic biomarkers in hematological malignancies. It is hoped that the evaluation of SNPs in CD markers will enable early diagnosis, prognosis, and detection of response to treatment. However, better understanding of SNPs in CD markers that are involved in hematological malignancies requires further studies on different populations of the worldwide. © Copyright: the Author(s), 2020
Related Docs
View other Related Docs
1. Cd44 Polymorphisms and Its Variants, As an Inconsistent Marker in Cancer Investigations, Mutation Research - Reviews in Mutation Research (2021)
2. Expression of Blood Cells Associated Cd Markers and Cardiovascular Diseases: Clinical Applications in Prognosis, Lab Medicine (2020)
3. Prognostic Significance of Aberrant Cd5 Expression in B-Cell Leukemia, Oncology Reviews (2019)
4. Involvement of Single Nucleotide Polymorphisms in Acute Lymphoblastic Leukemia Susceptibility, Gene Reports (2020)
5. What Are the Effects of Il-1Β (Rs1143634), Il-17A Promoter (Rs2275913) and Tlr4 (Rs4986790) Gene Polymorphism on the Outcomes of Infection With H. Pylori Within As Iranian Population; a Systematic Review and Meta-Analysis, Gene Reports (2020)
6. Evaluation of Rs62527607 [Gt] Single Nucleotide Polymorphism Located in Baalc Gene in Children With Acute Leukemia Using Mismatch Pcr-Rflp, Cancer Genetics (2016)
7. Single Cell Rna Sequencing Improves the Next Generation of Approaches to Aml Treatment: Challenges and Perspectives, Molecular Medicine (2025)
8. Effects of Abcg2 C421a and Abcg2 G34a Genetic Polymorphisms on Clinical Outcome and Response to Imatinib Mesylate, in Iranian Chronic Myeloid Leukemia Patients, Egyptian Journal of Medical Human Genetics (2023)
Experts (# of related papers)
View all Related Experts
Majid Ghanavat (3)
Pardis Nematollahi (2)
Other Related Docs
9. Transcription Analysis of a Histones Modifiers Panel Coupled With Critical Tumor Suppressor Genes Displayed Frequent Changes in Patients With Aml.: Mrna Levels of Histones Modifiers and Tsgs in Aml, Current Research in Translational Medicine (2021)
10. Immunophenotypic Aberrancy in Acute Leukemia – a Retrospective Single Institute Study, Polish Annals of Medicine (2021)
11. Potential Diagnostic Value of Abnormal Pyroptosis Genes Expression in Myelodysplastic Syndromes (Mds): A Primary Observational Cohort Study, International Journal of Hematology-Oncology and Stem Cell Research (2024)
12. Association of Programmed Death-1 Gene Polymorphisms With the Risk of Basal Cell Carcinoma, International Journal of Immunogenetics (2019)
13. Investigating the P53 Codon 72 Polymorphism in Patients With Chronic Myeloid Leukemia in Isfahan, Iran, Journal of Isfahan Medical School (2015)
14. Association Between (Gt)N Repeats in Heme Oxygenase-1 Gene Promoter and 3-Year Survival of Patients With Acute Leukemia: A Controlled, Cross-Sectional Study, International Journal of Hematology-Oncology and Stem Cell Research (2018)
15. Thrombocytopenia in Solid Tumors: Prognostic Significance, Oncology Reviews (2019)
16. Associations of a Tlr4 Single-Nucleotide Polymorphism With H.Pylori Associated Gastric Diseases in Iranian Patients, Clinics and Research in Hepatology and Gastroenterology (2014)
17. Singe Nucleotide Polymorphisms in Osteosarcoma: Pathogenic Effect and Prognostic Significance, Experimental and Molecular Pathology (2019)
18. P53 Ihc Result As a Prognostic Tool in Mds, Iranian Journal of Pathology (2023)
19. Programmed Cell Death 1 (Pdcd1) Gene Haplotypes and Susceptibility of Patients to Basal Cell Carcinoma, Molecular Biology Reports (2021)
20. Corelation of Homologous Recombination Repair System by Studying a Single-Nucleotide Polymorphism in Xrcc3 Gene With Initiation and Progression of Colorectal Cancer, Journal of Isfahan Medical School (2011)
21. The Association Between the C(-1562)T Polymorphism of Type Iv Collagenase Gene and Reduced Age of Onset of Lung Cancer, Journal of Isfahan Medical School (2012)
22. Genetic Variants of Nucleotide Excision Repair Pathway and Outcomes of Induction Therapy in Acute Myeloid Leukemia, Personalized Medicine (2019)